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Abstract
Background: Intraoperative driving pressure (ΔP) is associated with development of postoperative pulmonary
complications (PPC). When tidal volume (VT) is kept constant, ΔP may change according to positive end-expiratory
pressure (PEEP)-induced changes in lung aeration. ΔP may decrease if PEEP leads to a recruitment of collapsed lung
tissue but will increase if PEEP mainly causes pulmonary overdistension. This study tests the hypothesis that
individualized high PEEP, when compared to fixed low PEEP, protects against PPC in patients undergoing open
abdominal surgery.
Methods: The “Driving prESsure durIng GeNeral AnesThesIa for Open abdomiNal surgery trial” (DESIGNATION) is an
international, multicenter, two-group, double-blind randomized clinical superiority trial. A total of 1468 patients will
be randomly assigned to one of the two intraoperative ventilation strategies. Investigators screen patients aged ≥
18 years and with a body mass index ≤ 40 kg/m2, scheduled for open abdominal surgery and at risk for PPC.
Patients either receive an intraoperative ventilation strategy with individualized high PEEP with recruitment
maneuvers (RM) (“individualized high PEEP”) or one in which PEEP of 5 cm H2O without RM is used (“low PEEP”). In
the “individualized high PEEP” group, PEEP is set at the level at which ΔP is lowest. In both groups of the trial, VT is
kept at 8 mL/kg predicted body weight. The primary endpoint is the occurrence of PPC, recorded as a collapsed
composite of adverse pulmonary events.
Discussion: DESIGNATION will be the first randomized clinical trial that is adequately powered to compare the
effects of individualized high PEEP with RM versus fixed low PEEP without RM on the occurrence of PPC after open
abdominal surgery. The results of DESIGNATION will support anesthesiologists in their decisions regarding PEEP
settings during open abdominal surgery.
Trial registration: Clinicaltrials.gov, NCT03884543. Registered on 21 March 2019.
Keywords: Mechanical ventilation, Intraoperative ventilation, ΔP, Compliance, Positive end-expiratory pressure,
Recruitment maneuver , Pulmonary complications, Postoperative complications, Postoperative pulmonary
complications
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Background
Postoperative pulmonary complications (PPC) occur fre-
quently in patients undergoing major surgery [1] and
their development is associated with perioperative mor-
tality and morbidity [2]. Patients undergoing open ab-
dominal surgery are particularly at risk of developing
PPC, according to a high “Assess Respiratory Risk in
Surgical Patients in Catalonia for PPC” (ARISCAT) score
[3, 4]. Given that an estimated 55 million abdominal sur-
gical procedures are performed each year worldwide [1,
5], even a small reduction in the occurrence of PPC
would have a large impact on healthcare and costs.
Mechanical ventilation is an essential intervention dur-
ing general anesthesia for surgery, but carries a risk of
injuring lung tissue, leading to PPC. Intraoperative venti-
lation is one of the modifiable risk factors associated
with the development of PPC [6, 7]. Cyclic lung recruit-
ment and overdistension are two main mechanisms
responsible for the injurious effects of ventilation [8].
Intraoperative lung-protective ventilation with a low
tidal volume (VT) combined with high positive end-
expiratory pressure (PEEP) with recruitment maneuvers
(RM) prevents against PPC [2], but the precise role of
high PEEP and RM herein is highly uncertain. Three
randomized clinical trials (RCTs) showed intraoperative
ventilation with low VT plus high PEEP and RM to pre-
vent against PPC when compared with ventilation with
high VT plus low PEEP without RM [9–11]. Two other
RCTs, however, showed no benefit of high PEEP with
RM compared to low PEEP without RM, when VT was
kept low [12, 13].
It has been suggested that high PEEP should be ti-
trated so that it reduces cyclic recruitment, while at the
same time preventing overdistension [14]. An individual-
ized high PEEP strategy, avoiding an increase in driving
pressure (ΔP), or a decrease in respiratory system com-
pliance (CRS), may better protect against PPC than one
that uses fixed high PEEP. Until now, only two RCTs
have tested this hypothesis. One RCT in patients under-
going intraoperative ventilation for major abdominal
surgery did not show a benefit of individualized high
PEEP and RM for the primary endpoint of development
of postoperative complications. However, the individual-
ized PEEP strategy did reduce PPC, one of the secondary
endpoints of that study [15]. Another RCT, in patients
undergoing intraoperative one-lung ventilation for thor-
acic surgery, also showed an individualized high PEEP
strategy to protect against PPC [16], albeit at a low fra-
gility index [17]. Thus, the results of these two RCTs
should be interpreted with caution.
The aim of the “Driving prESsure durIng GeNeral
AnesThesIa for Open abdomiNal surgery trial” (DESIG-
NATION) is to compare intraoperative ventilation with
individualized high PEEP and RM versus ventilation with
a fixed low PEEP without RM in patients planned for
open abdominal surgery with respect to the development
of PPC. We hypothesize that the individualized high
PEEP strategy protects against PPC in this surgical
population.
Methods
Objectives and design
DESIGNATION is an international, multicenter,
prospective, two-group, double-blind RCT in patients
planned for open abdominal surgery and at risk of devel-
oping PPC. A total of 1468 patients will be recruited in
22 hospitals (Appendix 1) and randomly assigned to one
of the two to be tested intraoperative ventilation strat-
egies (see Consolidated Standards of Reporting Trials
diagram in Fig. 1).
DESIGNATION tests the premise that, in patients
planned for open abdominal surgery and at risk for PPC,
an individualized high PEEP strategy that aims at redu-
cing atelectasis but preventing overdistension better
protects against the development of PPC than a strategy
that uses a fixed high PEEP.
The trial has been approved by the Institutional
Review Board (IRB) of the Amsterdam University
Medical Centers, location “Academic Medical Center,”
Amsterdam, the Netherlands. DESIGNATION was
registered at clinicaltrials.gov on 21 March 2019 (study
identifier NCT03884543).
Study population
Local investigators screen patients aged ≥ 18 years with a
maximum body mass index (BMI) of 40 kg/m2 planned
for open abdominal surgery. The number of patients
meeting these enrollment criteria is recorded by means
of a screening log file. Patients are eligible if they are at
intermediate to high risk for PPC according to the ARIS-
CAT score (Table 1) [3].
Patients planned for laparoscopic surgery, for open ab-
dominal surgery combined with intra-thoracic surgery,
or for surgery in prone or lateral positions are excluded
from participation. Patients with a reported pregnancy,
patients who consented for another interventional study,
patients who did not have sufficient reflection time
before giving informed consent (i.e. < 12 h), and patients
declining to participate in DESIGNATION are not
eligible. Patients who have received mechanical ventila-
tion for > 30 min within the last 30 days before the
current surgery, patients who are expected to require
postoperative ventilation in the intensive care unit (ICU)
or post-anesthesia care unit, patients with persistent
hemodynamic instability or intractable shock, and
patients with severe cardiac disease (New York Heart
Association class [NYHA] III or IV, or acute coronary syn-
drome [ACS], or persistent ventricular tachyarrhythmias)
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are excluded. Other exclusion criteria are: any major pre-
vious lung surgery (e.g. lung resection); (previous) acute
respiratory distress syndrome (ARDS); history of previous
severe chronic obstructive pulmonary disease (COPD)
GOLD III or IV or with (non-invasive) ventilation and/or
oxygen therapy at home; and no written informed
consent.
Standard ventilation management
Patients in both groups are ventilated in volume-
controlled mode, at the lowest possible inspired oxygen
fraction (FiO2), but at least 0.4, to maintain oxygen sat-
uration > 90%. Inspiratory to expiratory ratio (I:E) is set
at 1:2 and the respiratory rate is adjusted to allow for
normocapnia (end-tidal carbon dioxide partial pressure
in the range of 35–45 mmHg [4.6–5.9 kPa]). Tidal vol-
ume is set at 8 mL/kg predicted body weight (PBW),
where PBW is calculated according to a predefined for-
mula: 50 + 0.91 × (centimeters of height – 152.4) for
men and 45.5 + 0.91 × (centimeters of height – 152.4)
for women [18].
Interventions
Patients assigned to the “individualized high PEEP”
group undergo a RM before and after the “decremental
PEEP trial,” after any disconnection from the ventilator
and within 1 h before extubation. RM are only per-
formed after assuring a stable hemodynamic situation, as
Fig. 1 Consolidated Standards of Reporting Trials (CONSORT) diagram for the “Driving prESsure durIng GeNeral AnesThesIa for Open abdomiNal
surgery” (DESIGNATION) trial
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judged by the attending anesthesiologist. During each
RM the ventilator remains in a volume-controlled venti-
lation mode, with the respiratory rate set at 15 breaths/
min. In steps of 15 s, PEEP is increased from 5 cm H2O
in steps of 5 cm H2O up to 20 cm H2O.
The decremental PEEP trial starts at the end of the
first RM at a PEEP of 20 cm H2O with the respiratory
rate set at 15 breaths/min. During the decremental PEEP
trial, the ventilator remains in volume-controlled ventila-
tion mode. Every 20 s, PEEP is decreased in steps of 2
cm H2O till a minimum level of 6 cm H2O. With every
step, the resulting ΔP is calculated by subtracting PEEP
from the plateau pressure (Pplat) at the end of each step.
ΔP is plotted against PEEP to construct a bedside “ΔP–
PEEP” graph, as shown in Fig. 2. From the ΔP–PEEP
graph, the highest level of PEEP with the lowest ΔP is
selected. If no nadir in ΔP is observed in the ΔP–PEEP
graph, 12 cm H2O PEEP will be used.
The decremental PEEP trial is followed by a second
RM, after which PEEP is set and kept at the level at
which ΔP is lowest, as indicated by the decremental
PEEP trial (Fig. 3).
Patients assigned to the “low PEEP” group are venti-
lated with a fixed 5 cm H2O PEEP for the complete dur-
ation of intraoperative ventilation. They will neither
receive RM nor a decremental PEEP trial.
Rescue therapies
In the “individualized high PEEP” group, desaturation
(defined as SpO2 ≤ 90% or if preoperative SpO2 < 90% an
absolute decrease in SpO2 > 5%) may still suggest
overdistension, despite a low ΔP. If desaturations in the
absence of airway problems, severe hemodynamic im-
pairment, or ventilator malfunction in this group occurs,
a rescue strategy is allowed in which PEEP is stepwise
decreased and eventually FiO2 is increased (Table 2).
In the “low PEEP” group, atelectasis may cause
desaturations. If desaturations in the absence of airway
problems, severe hemodynamic impairment, or ventila-
tor malfunction in this group occurs, a rescue strategy is
allowed where FiO2 is increased first, eventually followed
by RM and PEEP increases (Table 3).
If there is any concern about the patient’s safety or in
the unlikely event that PEEP interferes with the surgical
procedure, the ventilation settings can be changed at any
time. PEEP can be changed according to the decision by
the anesthesiologist in charge if any of the following pre-
approved reasons for protocol deviations occur:
hypotension, defined as a decrease in mean arterial pres-
sure (MAP) > 20% compared to preoperative MAP and
lasting > 3 min, not responding to intravenous fluids
and/or vasoactive drugs; new arrhythmias not respond-
ing to the treatment suggested by the Advanced Cardiac
Life Support Guidelines [19]; need for vasoactive drugs
at dosages higher than acceptable according to the
discretion of the anesthesiologist in charge; need for
massive transfusion, with > 5 units of blood to maintain
hematocrit > 21% (or hemoglobin > 7mg/dL); and
surgical complications determining life-threatening
situations. Any deviation from the protocol, other than
those mentioned above, are considered protocol viola-
tions. Protocol violations are to be reported and will be
discussed with the Data Safety Monitoring Board (DSMB).
Standard procedures beyond ventilator management
To avoid interference with the trial intervention, routine
general anesthesia, postoperative pain management,
physiotherapeutic procedures, and fluid management
will be used in the intraoperative and/or postoperative
period according to each center’s specific expertise and
routine clinical practice. However, adherence to the
enhanced recovery after surgery (ERAS) guidelines is
Table 1 Assess Respiratory Risk in Surgical Patients in Catalonia
scores
Risk for PPC of variables selected for the logistic regression model
Multivariate
analysis
Β
coefficients
Risk
score
OR (95% CI)
n = 1625
Age (years)
≤ 50 1
51–80 1.4 (0.6–3.3) 0.331 3
> 80 5.1 (1.9–13.3) 1.619 16
Preoperative SpO2 (%)
≥ 96 1
91–95 2.2 (1.2–4.2) 0.802 8
≤ 90 10.7 (4.1–28.1) 2.375 24
Respiratory infection in
last month
5.5 (2.6–11.5) 1.698 17
Preoperative anemia
(≤ 10 g/dL)
3.0 (1.4–6.5) 1.105 11
Surgical incision
Peripheral 1
Upper abdominal 4.4 (2.3–8.5) 1.480 15
Intrathoracic 11.4 (4.9–26.0) 2.431 24
Duration of surgery (h)
≤ 2 1
> 2–3 4.9 (2.4–10.1) 1.593 16
> 3 9.7 (4.7–19.9) 2.268 23
Emergency procedure 2.2 (1.04–4.5) 0.768 8
SpO2 oxyhemoglobin saturation by pulse oximetry breathing air in
supine position
High or intermediate risk for postoperative pulmonary complications following
abdominal surgery: ARISCAT risk score ≥ 26
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Fig. 2 Examples of the “ΔP–PEEP” graph. The arrow represents the optimal PEEP
Fig. 3 Overview of the intervention: the recruitment maneuvers and decremental PEEP trial. See text for a detailed description of the recruitment
maneuvers and the decremental PEEP trial. The numbers projected in each bar represent the duration of each step in seconds
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strongly recommended. These guidelines advise to per-
form postoperative pain management in order to achieve
a visual analog scale (VAS) pain score < 4 and to use re-
gional analgesia whenever indicated. Furthermore, the
guidelines suggest using physiotherapy by early
mobilization, deep breathing exercise with and without
incentive spirometry, and stimulation of cough in the
postoperative period. The guidelines recommend avoid-
ing fluid overload (according to the discretion of the at-
tending anesthesiologist) and to use appropriate
prophylactic antibiotics when indicated. Quantitative
neuromuscular monitoring (e.g. train-of-four [TOF]) is
required. Residual curarization should be excluded be-
fore extubation (e.g. TOF > 0.9).
Minimization of bias
Randomization is performed by the local investigators
using a dedicated and password protected randomization
module in Research Electronic Data Capture (REDCap).
Included patients will be randomly allocated in a 1:1 ratio
to the “individualized high PEEP” group or the “low PEEP”
group. The allocation sequence is computer-generated
and stratified per center and by BMI (≤ 30 vs > 30 kg/m2).
Permuted blocks of different block sizes are used, with a
maximum block size of eight.
At each site, at least two investigators are involved with
the study. One researcher will perform the randomization
directly before surgery and is responsible for intraopera-
tive ventilation and data collection. A second investigator
will remain blinded for the randomization arm and is re-
sponsible for the postoperative data collection.
The surgeon and patient are kept blind to the allo-
cated study intervention. Since PEEP can be adjusted at
any time point upon the surgeon’s request or because of
concerns about patient’s safety, and since patients do
not profit from knowing to which group they are allo-
cated to, unblinding is not applicable.
Study endpoints
The primary endpoint of DESIGNATION is a composite
of PPC occurring in the first five postoperative days.
This endpoint follows the European Perioperative Clin-
ical Outcome (EPCO) definition and has been used be-
fore in several RCTs [12, 15, 20].
The composite consists of the following PPC:
(i) severe respiratory failure, defined as need for non-
invasive or invasive mechanical ventilation, or a PaO2 <
60mmHg (or < 7.9 kPa) or SpO2 < 90% despite supple-
mental oxygen in spontaneously breathing patients;
(ii) bronchospasm, defined as newly detected expiratory
wheezing treated with bronchodilators;
(iii)suspected pulmonary infection defined as receiving
antibiotics and meeting at least one of the following
criteria: new or changed sputum, new or changed
lung opacities on chest radiograph when clinically
indicated, tympanic temperature > 38.3 °C, or white
blood cell count > 12,000/μL;
(iv) pulmonary infiltrate, defined as any unilateral or
bilateral infiltrates on chest radiography;
(v) aspiration pneumonitis, defined as respiratory failure
after the inhalation of regurgitated gastric contents;
(vi) atelectasis, defined as lung opacification with shift
of the mediastinum, hilum, or hemidiaphragm
towards the affected area, and compensatory
overinflation in the adjacent non-atelectasis lung on
chest radiography;
(vii)ARDS, according to the Berlin definition for ARDS [21];
(viii)pleural effusion, defined as blunting of the
costophrenic angle, loss of the sharp silhouette of
the ipsilateral hemidiaphragm in upright position,
evidence of displacement of adjacent anatomical
Table 2 Rescue for desaturation in the “individualized high
PEEP” group
Rescue for desaturation
Step PEEP FiO2
1 20 0.4
2 18 0.4
3 16 0.4
4 14 0.4
5 12 0.4
6 12 0.5
7 12 0.6
8 10 0.6
9 8 0.6
10 6 0.6
11 6 0.7
12 6 0.8
Down-titration of PEEP as rescue of desaturation. Starts at the level of PEEP set
after the decremental PEEP trial
Table 3 Rescue for desaturation in the “low PEEP” group
Rescue for desaturation
Step PEEP FiO2
1 5 0.4
2 5 0.5
3 5 0.6
4 5 0.7
5 5 0.8
6 6 0.8
7 RM
Up-titration of PEEP and recruitment maneuvers (RM) as rescue
of desaturation
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structures, or (in supine position) a hazy opacity in
one hemithorax with preserved vascular shadows
on chest radiography;
(ix)cardiopulmonary edema, defined as clinical signs of
congestion, including dyspnea, edema, rales and
jugular venous distention, with the chest radiograph
demonstrating increase in vascular markings and
diffuse alveolar interstitial infiltrates; and
(x) pneumothorax, defined as air in the pleural space
with no vascular bed surrounding the visceral
pleura on chest radiography.
Secondary endpoints include mild respiratory failure, de-
fined as a PaO2 < 60mmHg (or < 7.9 kPa) or SpO2 < 90% in
room air, but responding to supplemental oxygen (excluding
hypoventilation); intraoperative complications that are not
related to induction or change of depth of anesthesia and are
scored during steady state, including: desaturation (SpO2 ≤
90% or if preoperative SpO2 < 90% an absolute decrease in
SpO2 > 5% and lasting > 1min), hypotension (decrease in
MAP of > 20% and lasting for > 3min), any need for vaso-
active agents defined as more than needed to compensate
for vasodilating effects of anesthesia, and any new arrhyth-
mias needing intervention as suggested by the Advanced
Cardiac Life Support Guidelines [19]); intraoperative fluid
strategy; impaired wound healing; rate of all-cause mortality
and in-hospital mortality; unplanned admission to an ICU;
length of ICU (if applicable) and hospital stay; and postoper-
ative extrapulmonary complications including sepsis (accord-
ing to the SEPSIS-3 definition [22]), septic shock (defined as
sepsis with persisting hypotension requiring vasopressors to
maintain MAP ≥ 65 mmHg and having a serum lactate level
of > 2 mmol/L despite adequate fluid resuscitation) [22],
extrapulmonary infections (wound infection + any other in-
fection), anastomotic leakage, and acute renal failure (as de-
fined by the Acute Kidney Injury Network [AKIN] [23]).
Study visits and data collection
Patients are seen before surgery and followed during sur-
gery and daily during the first five postoperative days or
until hospital discharge, whatever occurs first. If patients
remain hospitalized after the first five postoperative days,
an extra visit at hospital discharge will be performed. Day
90 is defined as the last day of follow-up; accordingly, pa-
tients still admitted to the hospital will be last contacted
90 days after surgery. Patients are contacted by telephone
around day 30 and day 90 (Appendix 2).
Patients will be recruited at the anesthesiology or surgi-
cal outpatient clinic, or at the surgical ward. Individuals
will be informed verbally by local researchers and by a pa-
tient information letter (Additional file 2). The patient will
be given sufficient time to consider their decision and to
discuss the decision with their relatives or the independent
expert.
During the preoperative visit, after signing the informed
consent form, baseline variables are collected, including
age, gender, height, weight, American Society of
Anesthesiologist (ASA) score, functional status (independ-
ent, partially dependent, or totally independent), cardiac
status (hearth failure according to the NYHA, ACS, or
persistent ventricular tachyarrhythmias), and smoking sta-
tus. Pulmonary status, COPD, including inhalation ther-
apy and/or systemic steroids, respiratory infection within
the last month, and mechanical ventilation for > 30 min in
the last 30 days will be collected as well. Other baseline
variables are: history of active cancer; weight loss > 10% in
the last six months; history of diabetes mellitus and the
use of insulin or oral anti-diabetics; type of scheduled
surgery (emergency, urgent, or elective surgery); surgical
procedure; transfusion of blood products in the last 6 h;
and vital parameters (tympanic temperature, respiratory
rate, SpO2, blood pressure, VAS score for pain during
breathing, and heart rate). Blood tests (HbA1C, glucose,
urea, creatinine, hemoglobin, white blood cell count) and
chest imaging (assessed on mono- and bilateral infiltrate,
pleural effusion, atelectasis, pneumothorax, and cardiopul-
monary edema) are collected, but only if deemed neces-
sary for clinical care for the patient.
During the intraoperative period, variables are recorded
after induction, after RM, and hourly during anesthesia.
The intraoperative variables to be collected are: ventilator
settings; vital parameters; fluid and transfusion require-
ments; type and dose of administered vasoactive drugs;
need of rescue therapy for desaturation; intraoperative
complications possibly related to PEEP titrations; protocol
deviations and violations; duration of surgery; and dur-
ation and details of anesthesia (type of anesthesia, volatile
versus total intravenous anesthesia [TIVA] versus com-
bined, epidural analgesia, neuromuscular function moni-
toring). For the patients assigned to the “individualized
high PEEP” group, the plateau pressure will be docu-
mented at the end of each step of the decremental PEEP
trial. The bedside-constructed “ΔP–PEEP graph” will be
saved in the electronic database.
Postoperatively, clinical data and the presence of pul-
monary and extrapulmonary postoperative complications
are collected. Blood test and chest imaging will only be
taken if deemed necessary for clinical care of the patients.
Life status (death or alive) will be scored at the first five
postoperative days, on day 30 and day 90. Length of stay
in hospital, unplanned admission to an ICU, and length of
stay in the ICU are collected around day 90.
Study dropouts and missing data
Participation in the DESIGNATION trial is voluntary.
The number of drop-outs is expected to be very low. The
patient can withdraw consent for collecting study data
and for participation in the study at any time during the
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trial and without giving a reason for this. To minimize
patient drop-out due to cancellation of surgery,
randomization will be performed on the day of surgery
just before induction of anesthesia. Drop-out patients will
not be replaced. No or minimal losses to follow-up for the
primary and secondary outcomes are anticipated. Lost to
follow-up cases due to withdrawal of consent or for other
reasons will be excluded form analysis. If > 1% of missing
data were found for the primary outcome, a sensitivity
analysis using multiple imputations and estimating-
equation methods will be carried out.
Handling of data
Patient identifying personal data will be replaced by an
assigned code. Directly identifying data will only be used
to contact the patients and are only available for the local
investigators. Handling of personal data complies with the
general data protection regulations and applicable national
regulations. Data will be collected in an electronic case
report form (CRF) stored in REDCap. REDcap is a
password-protected, secure, web-based application, which
includes validation checks, audit trails, and appropriate
use access rights. After completing the data collection, full
access to the database will be granted to selected investi-
gators. Data are restricted, available after analyses and
publication of the main paper. All data will be stored in a
secure place for 15 years after study end.
The results of DESIGNATION will be published in
scientific journals and used for national and inter-
national guideline. A summary of the results will be
placed on clinicaltrials.gov to inform participants.
Sample size calculation
The required sample size is calculated based on an esti-
mated effect size derived from individual patient data
form previous clinical trials [9–12, 24]. A total of 720
patients per group are required, assuming a two-sided
significance level of 0.05 and a power of 80% to detect
the expected difference in the primary outcome between
a control group proportion of 34% and an experimental
group proportion of 27.2% (relative risk reduction of
20%). To allow for a dropout rate of 2% (based on
comparable RCTs of intraoperative ventilation per-
formed by our group), 734 patients per group (a total of
1468) are needed.
Statistical analysis
The detailed statistical analysis plan will be updated, fi-
nalized, and made available before the inclusion of the
last patient.
All statistical analyses will be conducted according to
the modified intention-to-treat principle considering all
patients in the treatment groups to which they were ran-
domly assigned, excluding cases lost to follow-up due to
withdrawal of consent or cancellation of surgery. Hy-
pothesis tests will be two-sided with a significance level
of 5% for all outcomes. Patient and baseline characteris-
tics will be compared and described by appropriate
statistics.
The effects of the intervention on the primary out-
come, occurrence of any PPC, will be reported as num-
ber and percentages and estimated with risk ratio and
95% confidence intervals (CI) calculated with Wald’s
likelihood ratio approximation test and with χ2 tests for
hypothesis testing. Kaplan–Meier curves will be used to
report time to PPC, and hazard ratios with a 95% CI will
be calculated with Cox proportional hazard models
without adjustment for covariates. The Schoenfeld resid-
uals against the transformed time will be used to test the
proportional hazard assumptions and alternative para-
metric survival models will be used if the proportionality
assumption is not sustained.
Treatment effects on incidence of PPC will be ana-
lyzed according to the following subgroups: (i) age < 65
years versus ≥ 65 years; (ii) BMI < 30 kg/m2 versus BMI ≥
30 kg/m2; (iii) baseline SpO2 < 96% versus SpO2 ≥ 96%;
(iv) moderate versus high risk for PPC; (v) duration of
surgery < 3 h versus ≥ 3 h; and (6) planned destination
to ICU or HDU versus ward. Analyses of heterogeneity
of effects across subgroups will performed with the use
of treatment-by-subgroup interaction term, added to a
generalized linear model considering a binomial distri-
bution, and will be presented in a forest plot.
The effect of the intervention on other binary out-
comes will be assessed with risk ratio and 95% CIs calcu-
lated with Wald’s likelihood ratio approximation test
and with χ2 tests for hypothesis testing. Time-to-event
data will be assessed using Kaplan–Meier curves, and
hazard ratios with a 95% CI will be calculated with Cox
proportional hazard models without adjustment for co-
variates. The Schoenfeld residuals against the trans-
formed time will be used to test the proportional hazard
assumptions and alternative parametric survival models
will be used if the proportionality assumption is not
sustained.
The effects of the intervention on length of
hospitalization and ICU stay will be estimated with gen-
eralized linear models considering distributions that will
fit a possible heavy right-tailed distribution without zero
(such as truncated Poisson, gamma distribution, or in-
verse Gaussian), choosing the best fit according to the
model’s deviance.
In all analyses, statistical uncertainties will be quanti-
fied with two-sided 95% CIs. A two-sided p value < 0.05
will be considered statistically significant. Additional
sensitivity analyses will be reported in the detailed statis-
tical analysis plan. Data analysis will be performed
blinded for the allocated study intervention.
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Trial organization
The steering committee consists of the two principal inves-
tigators, two trial coordinators, four international experts
on intraoperative ventilation who contributed to the design
of the study protocol, and the local investigators at partici-
pating study sites. The steering committee remains respon-
sible for the interpretation of the data and drafts the final
report that will be approved by all investigators.
An independent DSMB, consisting of four anesthesiol-
ogists with extensive clinical research experience (Daniel
Sessler [chair], Jennifer Hunter, Jeanine Wiener–Kro-
nisch, and Klaus Markstaller) will overview study
conduct and possible side effects of the study treatment
at 25%, 50%, and 75% of patient inclusions. A statistician
will report to the DSMB. All study-related or possibly
study-related (serious) adverse events (AEs) will be re-
ported to the DSMB. AEs are defined as any undesirable
experience occurring to a subject during the study,
whether or not considered related to the experimental
intervention. A serious AE (SAE) is any toward medical
occurrence or effect that results in death, is life-
threatening, requires hospitalization or prolongation of
existing inpatients’ hospitalization, results in persistent
or significant disability or incapacity, is a congenital
anomaly or birth defect, or any other important medical
event that did not result in any of the outcomes listed
above due to medical or surgical intervention but could
have been based upon appropriate judgement by the
investigator. SAEs related to the intervention will be dir-
ectly reported to the IRB. AEs related or possibly related
to the intervention and SAEs not related to the interven-
tion will be reported to the IRB in a line-listing.
This study is an investigator-initiated trial, funded by
“The Netherlands Organization for health Research and
Development” (ZonMw) and sponsored by the
Amsterdam University Medical Centers, location AMC.
The sponsor can suspend the study if there are sufficient
grounds that continuation of the study will jeopardize
the individuals’ health or safety.
An independent monitor will perform clinical trial
monitoring according to the monitor plan. Remote mon-
itoring will be performed to signal early aberrant pat-
terns, issues with consistency, credibility, and other
anomalies. On-site monitoring will comprise controlling
presence and completeness of the research dossier and
the informed consent forms, and source data check will
be performed as described in the monitoring plan. Cen-
tralized initiation meetings will be organized before sites
can start including patients.
A complete checklist of recommended items to ad-
dress in a clinical trial protocol and related documents
according to the “Standard Protocol Items: Recommen-
dations for Interventional Trials (SPIRIT) 2013” is pro-
vided (see Additional file 1).
Discussion
DESIGNATION tests the hypothesis that an “individual-
ized high PEEP” strategy, titrated to the level at which
ΔP is lowest, protects against development of PPC.
Mechanical ventilation is mandatory during general
anesthesia but has the potential to induce lung injury
promoting the development of PPC. Positive pressure
ventilation can result in overdistension of the aerated
parts of the heterogeneously aerated lung. Non- or
poorly aerated parts of the lung are prone for cyclic col-
lapse and recruitment. Both overdistension as well as
cyclic recruitment contributes to inflammation and in-
jury. Locally produced inflammatory mediators could
even leak to the circulation, eventually causing extrapul-
monary, or distal organ failure [7, 8].
In DESIGNATION, the primary endpoint is a col-
lapsed composite of PPC [20]. This endpoint has been
used before in several clinical trials of intraoperative
ventilation [12, 13, 15]. PPC can sensibly be combined
as they share common pathophysiological mechanism.
Each PPC seems to increase the risk of mortality and
length of hospital stay in surgical patients [4]. This
makes the composite of PPC a clinically relevant out-
come measure. Furthermore, using a composite outcome
measure increases the power of the study. In DESIGNA-
TION, both the composite endpoint as the incidence of
each PPC will be reported separately.
DESIGNATION also allows for determining the im-
pact of the intraoperative ventilation strategy on the oc-
currence of extrapulmonary complications and on the
length of stay in hospital and ICU. These endpoints are
not only seen as clinically relevant but are also needed
to understand the associated healthcare costs.
One meta-analyses demonstrated a lung-protective ef-
fect of intraoperative ventilation with low tidal volumes
[25]. Therefore, all participants in DESIGNATION will
receive ventilation with a low tidal volume (i.e. 8 mL/kg
predicted bodyweight). This is in line with current rec-
ommendations [25–27] and is used in previous clinical
trials of intraoperative ventilation before [12, 13, 15],
allowing for good comparison of the DESIGNATION re-
sults with those from preceding trials.
Although the beneficial effect of ventilation with a low
tidal volume is well established, the exact role of PEEP
remains controversial [9, 11–13, 28]. Two RCTs showed
that intraoperative ventilation with high PEEP does not
protect against the development of PPC when tidal vol-
umes are kept low [12, 13]. It had been suggested that
high PEEP should be titrated according to the lung’s
compliance or driving pressure. In the DESIGNATION
trial, the level of PEEP that results in the lowest ΔP will
be identified by the decremental PEEP trial. While in
one previous trial of individualized PEEP, an incremental
PEEP trial was used to find the best level of PEEP [16],
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here a decremental PEEP trial is chosen to ascertain that
the resulting PEEP sustains the beneficial effects of the
RM before the PEEP trial. This cannot be guaranteed
when using an incremental PEEP trial, because PEEP is
most likely below the closing pressure at start of an in-
cremental PEEP trial. This could theoretically result in
re-collapsing of certain lung parts [29], reversing the ef-
fect of the preceding RM.
The results of one systematic review and meta-analysis
suggest that a change in PEEP resulting in an increase of
ΔP increases the risk for PPC [14]. Previous trials of in-
dividualized PEEP did not use the PEEP resulting in the
lowest ΔP, or the highest compliance, but PEEP set sev-
eral cm H2O above the level that resulted in the lowest
ΔP [15, 30]. This approach, however, may very well re-
sult in additional overdistension, and is therefore not
followed in DESIGNATION. Indeed, in DESIGNA-
TION, PEEP is set to the exact level at which ΔP is the
lowest. If no nadir in the ΔP curve is present, PEEP will
be set at 12 cm H2O. This level is chosen because clin-
ical studies have shown PEEP of 12 cm H2O to result in
maximum lung opening throughout intraoperative venti-
lation, irrespective of the FiO2 [12, 31–35].
In DESIGNATION, throughout the whole period of
intraoperative ventilation, PEEP in the “individualized
high PEEP” group is set according to the results of the
“ΔP–PEEP graph” constructed soon after induction of
anesthesia. Although it is possible that lung mechanics
change during the surgical procedure, e.g. by manipula-
tions of abdominal organs by the surgeon, or a change
in position of the patient from a Trendelenburg position
to an anti-Trendelenburg position and vice versa, it is
decided not to repeat the decremental PEEP trial during
surgery. Since the surgical intervention might interfer-
ence with the result of the PEEP titration, a reliable dec-
remental PEEP trial can only be performed if the
surgeon temporarily stops the surgical intervention. This
would consume too much time and is considered not
feasible for this trial and clinical practice itself. DESIG-
NATION is a pragmatic study, and since ΔP is not ex-
pected to change comprehensively intraoperatively, it is
decided not to repeat the PEEP titrations during surgery
for the purpose of this study. Per design of the decre-
mental PEEP trial, the individualized high PEEP will only
result in PEEP in the range of 6–20 cm H2O. Neverthe-
less, 6 cm H2O PEEP can still result in overdistension.
Based on the results of previous investigations, the opti-
mal PEEP level is unlikely to be < 6 cm H2O [15, 30].
Therefore, the expected amount of overdistension in
DESIGNATION will be negligible.
Patients in the “low PEEP” group receive ventilation
with PEEP 5 cm H2O. The decision to use a PEEP of 5
cm H2O derives from previous trials of intraoperative
ventilation [15, 16]. PEEP 5 cm H2O is the most
frequently chosen level in daily practice [1, 36]; although
there is no absolute consensus on the best level of PEEP,
the overall recommendation is to ventilate patients with
healthy lungs with this PEEP level.
Patients in the “individualized high PEEP” group will
undergo at least three RMs during intraoperative ventila-
tion. RMs are performed by increases in PEEP during a
fixed time interval. This RM can be performed with all
types of anesthesia ventilators, ensuring standardization
of RM across different participating centers [15]. The
stepwise approach has shown to be effective in increas-
ing lung compliance and oxygenation without interrup-
tion of mechanical ventilation [11]. Furthermore, it
compares favorably to other types of RM, such as “bag
squeezing,” with respect to hemodynamic side effects
[28]. In contrast to patients in the “individualized high
PEEP” group, patients in the “low PEEP” group, will not
receive a RM. RM are added to the “individualized high
PEEP” group because applying PEEP without a RM has
proven to be ineffective in reducing atelectasis [37]. Of
note, in current daily practice, RM are not performed so
often [1]. To have a group of patients that received ven-
tilation representative for what is done in daily practice,
it was decided not to perform RM in the control group.
To avoid de-recruitment of the lungs, the RM will be re-
peated in the “individualized high PEEP” group after dis-
connection of the ventilator and within the last hour of
anesthesia.
To protect patients but minimize the interference with
the allocated PEEP level, rescue therapies are allowed.
To the best interest of patients, pre-approved protocol
deviations are permitted. Since these rescue therapies
and deviations influence the clinical applicability of the
“individualized high PEEP” strategy, both the use of
protocol deviations as rescue strategies will be collected.
Perioperative care will be performed to each center spe-
cific expertise and routine clinical use. However, to
minimize inference of clinical care on the study inter-
vention, it is suggested adhering to the ERAS guidelines.
In DESIGNATION, patients in the “individualized high
PEEP” group will receive a higher intraoperative PEEP
compared to the patients in the “low PEEP” group. Pre-
vious research showed higher PEEP levels to result in
more hypotension and higher need for vasoactive drugs
[12, 13]. To monitor the impact of mechanical ventila-
tion strategy on arterial blood pressure, intraoperative
oxygenation, and respiratory system mechanics, variables
regarding respiratory function and hemodynamics will
be collected hourly during anesthesia. The DSMB, con-
sisting of four members with expertise in clinical re-
search, is instituted to overview the study conduct and
possible side effects.
DESIGNATION aims at minimizing bias by using
concealed allocation and blinding of the outcome
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assessor. REDcap, a secure web-based electronic
password protected system, is used as database and
randomization tool. REDcap randomization allocation
sequence is computer-generated using a permuted block
of different sizes. To minimize bias, randomization is
stratified per center. Since obesity is an important factor
influencing patient’s respiratory function during general
anesthesia [38–40], randomization is also stratified by
BMI (≤ 30 vs > 30 kg/m2).
DESIGNATION will be performed in both community
and teaching hospitals in different countries of Europe,
making the results generalizable. Intra-abdominal hyper-
tension during a laparoscopic surgical procedure will
have a considerable impact on lung mechanics [41–43].
For this reason, patients planned to undergo a laparo-
scopic surgical procedure are excluded from participa-
tion in DESIGNATION, even if the procedure is only
laparoscopic assisted. There is a clear trend from open
to laparoscopic surgery, and probably the number open
abdominal procedures will decrease significantly. If DES-
IGNATION shows an individualized high PEEP strategy
to be beneficial, additional trials testing the effects of
personalized PEEP on occurrence of PPC will be needed.
In summary, DESIGNATION will be the first suffi-
ciently powered, multicenter RCT to test whether a ven-
tilation strategy of individualized high PEEP with RM is
superior to one that uses fixed low PEEP of 5 cm H2O
without RM with respect to development of PPC in pa-
tients planned for open abdominal surgery. The results
of DESIGNATION will support anesthesiologists in their
decision to set intraoperative PEEP during protective
ventilation for general anesthesia during open abdominal
surgery.
Trial status
The current approved version of the protocol is version 4.2,
issue data: 11 December 2019. DESIGNATION trial is cur-
rently recruiting patients. Recruitment started in April 2019
and will be completed in approximately April 2022.
Medical terminology (in order of appearance)
Driving pressure: the pressure that results from moving
air into the lungs; driving pressure is calculated by dis-
tracting the PEEP from plateau airway pressure or by
dividing tidal volume by respiratory system compliance.
Postoperative pulmonary complications: spectrum of
complications affecting the respiratory system and develop-
ing after ventilation for general anesthesia during surgery.
Tidal volume: the volume of air moved into and out of
the lungs during each ventilation cycle.
Positive end-expiratory pressure: positive pressure dur-
ing expiration, meant to keep maintain the airway pres-
sure above the atmospheric level.
Open abdominal surgery: surgical procedure per-
formed in the abdominal region requiring a large inci-
sion; laparoscopic devices are not used.
Cyclic lung recruitment: repetitive collapse and re-
expansion of atelectatic lung tissue during each breath.
Overdistension: excessive stretching of (parts of) the
lungs.
Recruitment maneuver: procedure is used for reinfla-
tion of collapsed lung units.
Respiratory system compliance: change in volume of
the lungs for each unit increase in airway pressure; in
other words; the ease with which the lungs can be
inflated.
“High PEEP”: an applied PEEP level of > 5 cm H2O.
Volume-controlled (ventilation) mode: the artificial
breath is delivered at a constant and predetermined in-
spiratory flow-time profile, with a fixed tidal volume.
Inspired oxygen fraction: the volumetric fraction of
oxygen in the inhaled gas.
End-tidal carbon dioxide partial pressure: concentra-
tion of carbon dioxide at the end of exhalation.
Predicted bodyweight: the ideal body weight, calcu-
lated based on patients’ gender and height; used to
normalize tidal volume to lung size.
Desaturation: situation in which the percentage of
hemoglobin bindings sites in the bloodstream occupied
by oxygen gets < 90%.
Train-of-four: a peripheral nerve simulation test,
used to assess neuromuscular transmission when
neuromuscular blocking agents are given to block
musculoskeletal activity.
Volatile anesthesia: technique of general anesthesia
that uses inhalation anesthetics.
Total intravenous anesthesia: technique of general
anesthesia that uses a combination of drugs given exclu-
sively by the intravenous route, i.e. without use of vola-
tile anesthesia.
Collapsed composite endpoint: endpoint that is a com-
bination of multiple clinical endpoints; endpoints are
combined because they are considered to be of similar
importance, occur with about the same frequency, have
similar relative risk reductions, and have similar biologic
mechanisms.
Incremental PEEP trial: progressively increasing PEEP
with a constant tidal volume.
Decremental PEEP trial: starting at a high PEEP and
progressively reducing it with a constant tidal volume.
Trendelenburg position: variant of the supine pos-
ition in which the table is tilted with the head down
and feet up.
Anti-Trendelenburg: variant of the supine position in
which the table is tilted with the head up and feet down.
Bag squeezing: a type of recruitment maneuver per-
formed manually by using an anesthesia bag.
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Appendix 1
Table 4 DESIGNATION investigators
Site ID Site name Collaborator(s)
104 Department of Anesthesiology, Albert Schweitzer Hospital, Dordrecht, the Netherlands Stamkot, André
Kortekaas, Minke C.
Koopman – van Gemert, Ankie W.M.M.
114 Department of Anesthesiology, Amsterdam University Medical Center location AMC, Amsterdam,
the Netherlands
Hollmann, Markus W.
Schultz, Marcus J.
Preckel, Benedikt
Hemmes, Sabrine N.T.
Serpa Neto, Ary
Nijbroek, Sunny G.L.H.
Hol, Liselotte
97 Department of Anesthesiology, Amsterdam University Medical Center location VUmc, Amsterdam,
the Netherlands
Bulte, Carolina S.E.
Albersen, Juliette J.E
Boer, Christa
118 Department of Anesthesiology, Bergmannstrost Klinikum, Halle, Germany Wrigge, Hermann
101 Department of Anesthesiology, Bernhoven Hospital, Uden, the Netherlands Hoogenboom, Hester
107 Department of Anesthesiology, Erasmus Medical Center, Rotterdam, the Netherlands Van Lier, Felix
Stolker, Robert Jan
103 Department of Anesthesiology, Haaglanden Medical Center in The Hague, the Netherlands In ‘t Veld, Bastiaan A.
Houweling, Bernard M.
102 Department of Anesthesiology, HAGA Hospital, The Hague, the Netherlands Van der Zwan, Tim
Rad, Mandana
117 Department of Anesthesiology, IRCCS Ospedale Policlinic San Martino, Genoa, Italy Pelosi, Paolo
Battaglini, Denise
105 Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands Aarts, Leon P.H.J.
Helmerhorst, Hendrik J.F.
Akkerman, Ronald D.L.
113 Department of Anesthesiology, Maastricht University Medical Center, Maastricht, the Netherlands Ubben, Johannes F.H.
De Korte – de Boer, Dianne
Buhre, Wolfgang F.F.A.
106 Department of Anesthesiology, Pain Medicine and Procedural Sedation and Analgesia, Martini
General Hospital, Groningen, the Netherlands
De Boer, Hans D.
109 Department of Anesthesiology, Medical Center Leeuwarden, Leeuwarden, the Netherlands Brouwer, Tammo
96 Department of Anesthesiology, NoordWest Ziekenhuisgroep, Alkmaar, the Netherlands Zwijsen, Johannes H.M.J.
Edward-Rutten, Gitara M.
98 Department of Anesthesiology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands Godfried, Marc B.
Thiel, Bram
108 Department of Anesthesiology, Radboud University, Nijmegen, the Netherlands Hofland, Jan
100 Department of Anesthesiology, Rijnstate, Arnhem, the Netherlands Ten Hoope, Werner
99 Department of Anesthesiology, Spaarne Gasthuis, Haarlem and Hoofddorp, the Netherlands Boom, Annemieke
115 Department of Anesthesiology, University Hospital Carl Gustav Carus, Dresden, Germany Gama de Abreu, Marcelo
119 Department of Anesthesiology, University Hospital of Düsseldorf, Düsseldorf, Germany Huhn, Ragnar
106 Department of Anesthesiology, University Medical Center Groningen, Groningen, the Netherlands Struys, Michel M.R.F.
Zeillemaker-Hoekstra, Miriam
116 Department of Anesthesiology, University of Napoli, Napoli, Italy Sansone, Pasquale
Aurilio, Caterina
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